Welcome
Support Centre
18 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effects of Mediterranean diet on the primary prevention of cardiovascular disease
ISRCTN ISRCTN35739639
ClinicalTrials.gov identifier
Public title Effects of Mediterranean diet on the primary prevention of cardiovascular disease
Scientific title
Acronym PREDIMED STUDY
Serial number at source Red G03/140
Study hypothesis A Mediterranean-style diet enriched with virgin olive oil or mixed nuts prevents cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke).
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Spain
Disease/condition/study domain Cardiovascular disease
Participants - inclusion criteria Participants are community-dwelling high-risk persons with age 55 to 80 years for men and 60 to 80 years for women, without a History of Cardiovascular Disease (CHD), who fulfill at least one of the two following criteria:
1. Type two diabetes
2. Three or more of the risk factors:
2.1. Current smoker
2.2. Hypertension
2.3. Hypercholesterolemia (low Density Lipoprotein cholesterol [LDL-cholesterol] more than 160 mg/dl or treatment with hypolipidemic drugs)
2.4. High Density Lipoprotein cholesterol (HDL-cholesterol) less than 40 mg/dl
2.5. Overweight or obesity (Body mass index more than 25 kg/m^2)
2.6. Family history of premature CHD
Participants - exclusion criteria 1. Previous history of cardiovascular disease
2. Any severe chronic illness
3. Immunodeficiency or Human Immunodeficiency Virus (HIV) positive status
4. Illegal drug use or chronic alcoholism
5. History of allergy to olive oil or nuts
6. Low predicted likelihood of changing dietary habits according to the Prochaska and DiClemente stages of change model
Anticipated start date 01/10/2003
Anticipated end date 31/12/2010
Status of trial Ongoing
Patient information material
Target number of participants n = 9000 high-risk participants
Interventions Participants are randomly assigned into three equal groups:
1. Mediterranean-style diet with added virgin olive oil
2. Mediterranean-style diet with added nuts
3. Low-fat diet according to American Heart Association guidelines
Primary outcome measure(s) A composite endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke.
Secondary outcome measure(s) Death of any cause and incidence of angina leading to a revascularisation procedure, heart failure, diabetes mellitus, dementia, and cancer.

Other outcomes:
1. Changes in blood pressure
2. Body weight
3. Adiposity measures
4. Blood sugar
5. Lipid profile
6. Markers of inflammation
7. Other intermediate markers of cardiovascular risk
Sources of funding 1. Institute of Health Carlos III (Instituto de Salud Carlos III) (Spain) (ref: G03/140)
2. Communal Patrimony Olivarero Foundation (Fundación Patrimonio Comunal Olivarero) (Spain)
3. Hojiblanca SA (Spain)
4. Borges SA (Spain)
5. Morella Nuts SA (Spain)
6. California Walnut Commission (USA)
Trial website http://www.predimed.org
Publications Results in:
1. http://www.ncbi.nlm.nih.gov/pubmed/16818923
2. http://www.ncbi.nlm.nih.gov/pubmed/17563030
Contact name Prof  Ramon  Estruch
  Address Servicio de Medicina Interna
Hospital Clinic
Villarroel, 170
  City/town Barcelona
  Zip/Postcode 08036
  Country Spain
  Tel +34 93 2279365
  Fax +34 93 2279365
  Email restruch@clinic.ub.es
Sponsor Institute of Health Carlos III (Instituto de Salud Carlos III) (Spain)
  Address Sinesio Delgado, 6
  City/town Madrid
  Zip/Postcode 28029
  Country Spain
  Tel +34 918222100
  Fax +34 913877789
  Email Oficina.informacion@isciii.es
  Sponsor website: http://www.isciii.es
Date applied 02/09/2005
Last edited 19/02/2008
Date ISRCTN assigned 05/10/2005
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central